3.1. Study Population
Twenty patients (75.0% females and 25.0% males; median age 49.0 years, IQR 41.0–53.0) were randomized to the administration via NGT (ProMoFasT group), while 24 patients (58.3% females and 41.7% males; mean age 49.0 years, IQR 39.0–56.5) were assigned to the PSMF diet administration orally (oral group) (